The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Access · Pricing · continued

Pen wastage and its effect on real cost posts 31–34

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.

TT
taper_tableTL3Regular4 Oct 2024 · edited#31
w.verhoeven, post #1: Pen wastage and its effect on real cost Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that is what determines the answer. Denial received, with a stated reason. My reading of the reason is that it tells me exactly what to submit next,… Go to post

I disagree with the reply above, and I think the disagreement is substantive rather than terminological.

The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.

0 likes in reply to #1 22mo
MA
m.agyemanTL2 Moderator7 Oct 2024#32

I read post #30 twice before replying, because I had assumed the opposite.

List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance company or pharmacy actually pays differ substantially. List price is not what anyone pays.

2 likes 22mo
H
HRouhaniTL1Member10 Oct 2024#33

post #32 is right about the mechanism and I think understates the practical bit.

Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live.

8 likes 22mo
TV
t.verhoevenTL2 Moderator13 Oct 2024#34

Discount programmes and coupons: manufacturers often offer coupons that reduce out-of-pocket costs if insurance is not covering or is covering at a high copay. These have eligibility restrictions but can save money.

19 likes 21mo

Suggested topics

TopicParticipantsRepliesViewsActivity
List price versus negotiated price versus what you pay
On the subject in the title: List price versus negotiated price versus what you pay Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires.…
JPJAVFVBCA+99 115 11k 3mo
About the Pricing category
List prices, negotiated prices, and cost per milligram compared honestly across formats. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its…
JMBNHFDTMP+1 5 18k 15mo
Cost per milligram, computed honestly across formats — a second dataset
Cost per milligram, computed honestly across formats — a second dataset Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail…
NKSHFF 2 27k 13mo
Second pass at: Manufacturer assistance programmes and their eligibility rules
Second pass at: Manufacturer assistance programmes and their eligibility rules — setting out what I have, and where I think it stops being reliable. Documenting an access outcome, dated, because everything in…
JDLAPOHNKK+13 17 1.8k 16mo
Comparing prices across jurisdictions without misleading yourself
Comparing prices across jurisdictions without misleading yourself — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is…
LCGFVTPOO+78 83 33k 1mo

Related topics — sharing the tags cost per milligram, compounding, formulary

TopicParticipantsRepliesViewsActivity
Interpreting a composition change that is within the error bars
On the subject in the title: Interpreting a composition change that is within the error bars Working notes rather than a conclusion. Longitudinal report with the method stated, because a number without a…
VBWMDMMEK+18 22 5.8k 12mo
What a regulator's shortage notice actually authorises — what changed since
The question in the title: What a regulator's shortage notice actually authorises — what changed since I will give what I have already checked below so nobody repeats it. A logistics question, since the…
JMMBUCRVW+22 26 53k 7mo
Pharmacy supply in the UK and the questions you will be asked
On the subject in the title: Pharmacy supply in the UK and the questions you will be asked Working notes rather than a conclusion. A coverage question with the paperwork detail included, since that is what…
CMCBRMNSP+95 105 1.3k 4mo
Hoarding and why it makes a shortage worse
Posting this under the heading it deserves: Hoarding and why it makes a shortage worse Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this category…
MKKK 2 12k 22mo
What I would record differently if I started again — the long version
What I would record differently if I started again — the long version I have a specific reason for asking rather than idle curiosity, and the context is below. Maintenance rather than loss, which is the part…
VMHMRLEVLO+22 26 57k 5mo